BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

673 related articles for article (PubMed ID: 27374606)

  • 1. Diagnosis, Clinical Course, and 1-Year Outcome in Patients Hospitalized for Heart Failure With Preserved Ejection Fraction (from the Polish Cohort of the European Society of Cardiology Heart Failure Long-Term Registry).
    Kapłon-Cieślicka A; Tymińska A; Peller M; Balsam P; Ozierański K; Galas M; Marchel M; Crespo-Leiro MG; Maggioni AP; Drożdż J; Filipiak KJ; Opolski G
    Am J Cardiol; 2016 Aug; 118(4):535-42. PubMed ID: 27374606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is heart failure misdiagnosed in hospitalized patients with preserved ejection fraction? From the European Society of Cardiology - Heart Failure Association EURObservational Research Programme Heart Failure Long-Term Registry.
    Kapłon-Cieślicka A; Laroche C; Crespo-Leiro MG; Coats AJS; Anker SD; Filippatos G; Maggioni AP; Hage C; Lara-Padrón A; Fucili A; Drożdż J; Seferovic P; Rosano GMC; Mebazaa A; McDonagh T; Lainscak M; Ruschitzka F; Lund LH;
    ESC Heart Fail; 2020 Oct; 7(5):2098-2112. PubMed ID: 32618139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction.
    Linssen GC; Rienstra M; Jaarsma T; Voors AA; van Gelder IC; Hillege HL; van Veldhuisen DJ
    Eur J Heart Fail; 2011 Oct; 13(10):1111-20. PubMed ID: 21642293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Care and outcomes of Hispanic patients admitted with heart failure with preserved or reduced ejection fraction: findings from get with the guidelines-heart failure.
    Vivo RP; Krim SR; Krim NR; Zhao X; Hernandez AF; Peterson ED; Piña IL; Bhatt DL; Schwamm LH; Fonarow GC
    Circ Heart Fail; 2012 Mar; 5(2):167-75. PubMed ID: 22414939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of heart failure with preserved ejection fraction in Latin American, Middle Eastern, and North African Regions in the I PREFER study (Identification of Patients With Heart Failure and PREserved Systolic Function: an epidemiological regional study).
    Magaña-Serrano JA; Almahmeed W; Gomez E; Al-Shamiri M; Adgar D; Sosner P; Herpin D;
    Am J Cardiol; 2011 Nov; 108(9):1289-96. PubMed ID: 22000627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of heart failure with preserved ejection fraction in a Southeast Asian cohort.
    Hoong CW; Lim CP; Gao F; Chen Q; Kawa LB; Ching CK; Sim DK
    J Cardiovasc Med (Hagerstown); 2015 Sep; 16(9):583-90. PubMed ID: 25022929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in biomarkers in patients with heart failure with a reduced vs a preserved left ventricular ejection fraction.
    de Denus S; Lavoie J; Ducharme A; O'Meara E; Racine N; Sirois MG; Neagoe PE; Zhu L; Rouleau JL; White M
    Can J Cardiol; 2012; 28(1):62-8. PubMed ID: 22104539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of mortality and morbidity in patients with atrial fibrillation and heart failure with preserved versus decreased left ventricular ejection fraction.
    Badheka AO; Rathod A; Kizilbash MA; Bhardwaj A; Ali O; Afonso L; Jacob S
    Am J Cardiol; 2011 Nov; 108(9):1283-8. PubMed ID: 21855829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of heart failure symptoms and ejection fraction on short- and long-term outcomes for older patients with non-ST-segment elevation myocardial infarction.
    van Diepen S; Chen AY; Wang TY; Alexander KP; Ezekowitz JA; Peterson ED; Roe MT
    Am Heart J; 2014 Feb; 167(2):267-273.e1. PubMed ID: 24439989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between sex, ejection fraction, and B-type natriuretic peptide levels in patients hospitalized with heart failure and associations with inhospital outcomes: findings from the Get With The Guideline-Heart Failure Registry.
    Hsich EM; Grau-Sepulveda MV; Hernandez AF; Eapen ZJ; Xian Y; Schwamm LH; Bhatt DL; Fonarow GC
    Am Heart J; 2013 Dec; 166(6):1063-1071.e3. PubMed ID: 24268222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis.
    Meta-analysis Global Group in Chronic Heart Failure (MAGGIC)
    Eur Heart J; 2012 Jul; 33(14):1750-7. PubMed ID: 21821849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry.
    Chioncel O; Lainscak M; Seferovic PM; Anker SD; Crespo-Leiro MG; Harjola VP; Parissis J; Laroche C; Piepoli MF; Fonseca C; Mebazaa A; Lund L; Ambrosio GA; Coats AJ; Ferrari R; Ruschitzka F; Maggioni AP; Filippatos G
    Eur J Heart Fail; 2017 Dec; 19(12):1574-1585. PubMed ID: 28386917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction.
    Kristensen SL; Køber L; Jhund PS; Solomon SD; Kjekshus J; McKelvie RS; Zile MR; Granger CB; Wikstrand J; Komajda M; Carson PE; Pfeffer MA; Swedberg K; Wedel H; Yusuf S; McMurray JJ
    Circulation; 2015 Jan; 131(1):43-53. PubMed ID: 25406306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes in patients with heart failure with preserved ejection fraction.
    Poppe KK; Doughty RN
    Heart Fail Clin; 2014 Jul; 10(3):503-10. PubMed ID: 24975912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of renal dysfunction phenotype on mortality in decompensated heart failure with preserved and mid-range ejection fraction.
    Casado J; Sánchez M; Garcés V; Manzano L; Cerqueiro JM; Epelde F; García-Escrivá D; Pérez-Silvestre J; Morales JL; Montero-Pérez-Barquero M;
    Int J Cardiol; 2017 Sep; 243():332-339. PubMed ID: 28528982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart failure with recovered ejection fraction: a distinct clinical entity.
    Punnoose LR; Givertz MM; Lewis EF; Pratibhu P; Stevenson LW; Desai AS
    J Card Fail; 2011 Jul; 17(7):527-32. PubMed ID: 21703523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Outcomes of Atrial Fibrillation in Patients With Reduced Versus Preserved Left Ventricular Ejection Fraction.
    Benjamin MM; Chaddha A; Sampene E; Field ME; Rahko PS
    Am J Cardiol; 2016 Dec; 118(12):1831-1835. PubMed ID: 28029361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anemia at Hospital Admission and Its Relation to Outcomes in Patients With Heart Failure (from the Polish Cohort of 2 European Society of Cardiology Heart Failure Registries).
    Tymińska A; Kapłon-Cieślicka A; Ozierański K; Peller M; Balsam P; Marchel M; Crespo-Leiro MG; Maggioni AP; Jankowska EA; Drożdż J; Filipiak KJ; Opolski G
    Am J Cardiol; 2017 Jun; 119(12):2021-2029. PubMed ID: 28434647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival After Coronary Artery Bypass Grafting in Patients With Preoperative Heart Failure and Preserved vs Reduced Ejection Fraction.
    Dalén M; Lund LH; Ivert T; Holzmann MJ; Sartipy U
    JAMA Cardiol; 2016 Aug; 1(5):530-8. PubMed ID: 27434816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life is impaired similarly in heart failure patients with preserved and reduced ejection fraction.
    Hoekstra T; Lesman-Leegte I; van Veldhuisen DJ; Sanderman R; Jaarsma T
    Eur J Heart Fail; 2011 Sep; 13(9):1013-8. PubMed ID: 21712287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.